LFVN Lifevantage

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2021 Results on August 19, 2021

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2021 Results on August 19, 2021

SALT LAKE CITY, Aug. 05, 2021 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2021, after the stock market closes on Thursday, August 19, 2021. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. or international callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, August 26, 2021, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13721246, or (412) 317-6671 from international locations, and entering confirmation code 13721246.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at or directly at . The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements and skin and hair care products, including its Protandim® product line, LifeVantage® Omega+, ProBio and Daily Wellness dietary supplements, the TrueScience® line of Nrf2 infused skin, hair, bath & body, and targeted relief products, Petandim® for Dogs, Axio® nootropic energy drink mixes, and the PhysIQ™ smart weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit

Investor Relations Contact:

Reed Anderson, ICR

(646) 277-1260



EN
05/08/2021

Underlying

LFVNLifevantage

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lifevantage

 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage to Participate in the LD Micro Main Event XIX on October 2...

LifeVantage to Participate in the LD Micro Main Event XIX on October 20, 2025 SALT LAKE CITY, Oct. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer will participate in the LD Micro Main Event XIX, to be held October 19-21, 2025 in San Diego, CA. Mr. Fife will meet with investors and present at approximately 5:30 p.m. Eastern Time on Monday, October 20, 2025. A live webcast of the...

October 13, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Closing of LoveBiome Acquisition

LifeVantage Announces Closing of LoveBiome Acquisition Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market SALT LAKE CITY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transa...

October 2, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter ...

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2025. Fourth Quarter Fiscal 2025 Summary*: Revenue of $55.1 million, an increase of 12.6% from the prior year period. Excluding the impact of foreign currency fluctuations, fourth quarter r...

September 4, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership i...

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness Strategic acquisition expands network of Consultants, and strengthens LifeVantage's Activation differentiation in the rapidly growing gut health market SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company...

September 3, 2025 1 EN
 PRESS RELEASE
Free
LFVN LIFEVANTAGE

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global I...

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY. Mr. Fife and Mr. Aure will meet with investors and...

September 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch